Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January…
40,444$
0,46%
Echtzeit-Aktienkurs Crinetics Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Crinetics Pharmaceuticals Inc. Aktie
Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness
…
Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December…
Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript
…
Crinetics Pharmaceuticals Inc.: Erwarteter Umsatzanstieg von 4 Mio. auf 160 Mio. USD dank bevorstehender Markteinführung
Mit seinen innovativen Therapien für unterversorgte Zielgruppen hat der Megatrend Biopharmazeutika bereits einige attraktive Anlageoptionen für Investoren hervorgebracht. Allen voran…
Crinetics Pharmaceuticals prices $500M equity at $50 per share
…
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused…
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on September…
Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2024 Earnings Call Transcript
…
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July…
Crinetics Pharmaceuticals exec sells shares worth over $645,000 By Investing.com
Crinetics Pharmaceuticals exec sells shares worth over $645,000…
Crinetics Pharmaceuticals files for mixed shelf, to sell shares for holders
…
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June…
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2024 Earnings Call Transcript
…
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May…
How to Invest in Biotechnology (Updated 2024)
Investors interested in the life science sector are well aware of the importance of biotechnology.From finding cures for diseases to…
Crinetics Pharmaceuticals exec sells over $664k in company stock By Investing.com
Crinetics Pharmaceuticals exec sells over $664k in company stock…
Crinetics Pharmaceuticals director Fust sells shares worth over $2.6m By Investing.com
Crinetics Pharmaceuticals director Fust sells shares worth over $2.6m…
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMYs CAR T Cell Therapy News & More
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.…
Crinetics Pharmaceuticals CFO sells shares worth nearly $300k By Investing.com
Crinetics Pharmaceuticals CFO sells shares worth nearly $300k…
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
Crinetics Pharmaceuticals (CRNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2023 Earnings Call Transcript
…
Crinetics Pharmaceuticals secures $350 million in placement By Investing.com
Crinetics Pharmaceuticals secures $350 million in placement…
Crinetics Pharmaceuticals issues stock options to new hires By Investing.com
Crinetics Pharmaceuticals issues stock options to new hires…
Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February…
Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January…
Crinetics Pharmaceuticals Announces December 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Crinetics Pharmaceuticals: Some Caution Warranted
…
Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester
Prominent somatostatin analogs market players include Sun Pharmaceutical Industries Limited, Novartis AG, Biodexa Pharmaceuticals PLC, Ipsen Pharma, Pfizer Inc., Teva…
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Somatostatin Analogs Market revenue to reach USD 10 Billion by 2035, says Research Nester
Prominent somatostatin analogs market players include Sun Pharmaceutical Industries Limited, Novartis AG, Biodexa Pharmaceuticals PLC, Ipsen Pharma, Pfizer Inc., Teva…
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that company management…
Crinetics Pharmaceuticals prices $350.0 million upsized stock offering
…
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused…
: Crinetics Pharmaceuticals shares surge 65%, analysts raise price target after acromegaly treatment results
Shares of Crinetics Pharmaceuticals Inc. CRNX gained 65% premarket on Monday after the company announced positive results from a late-stage…
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Form 10-Q Crinetics Pharmaceutical For: Jun 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Crinetics Pharmaceutical For: Aug 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly
Webinar Being Held on August 8, 2023 at 12:00 p.m. Eastern Time Webinar Being Held on August 8, 2023 at…
Insiderhandel: President & CEO verkauft Aktien von Crinetics Pharmaceuticals im Wert von 491.094$
Struthers, Richard Scott - Vorstand - Tag der Transaktion: 2023-07-11...…
Insiderhandel: President & CEO verkauft Aktien von Crinetics Pharmaceuticals im Wert von 231.128$
Struthers, Richard Scott - Vorstand - Tag der Transaktion: 2023-07-12...…
Insiderhandel: President & CEO verkauft Aktien von Crinetics Pharmaceuticals im Wert von 288.095$
Struthers, Richard Scott - Vorstand - Tag der Transaktion: 2023-07-13...…
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, July 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Insiderhandel: President & CEO verkauft Aktien von Crinetics Pharmaceuticals im Wert von 1.040.500$
Struthers, Richard Scott - Vorstand - Tag der Transaktion: 2023-06-16...…
Insiderhandel: CFO verkauft Aktien von Crinetics Pharmaceuticals im Wert von 617.403$
Wilson, Marc - Vorstand - Tag der Transaktion: 2023-06-20...…
Form 8-K Crinetics Pharmaceutical For: Jun 16
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company…
Insiderhandel: Aufsichtsrat kauft Aktien von Crinetics Pharmaceuticals im Wert von 110.300$
Vivaldi, Coelho Rogerio - Aufsichtsrat - Tag der Transaktion: 2023-06-08...…